EPA guidance on assessment of negative symptoms in schizophrenia

EPA guidance on assessment of negative symptoms in schizophrenia

AbstractBackgroundDuring the last decades, a renewed interest for negative symptoms (NS) was brought about by the increased awareness that they interfere severely with real-life functioning, particularly when they are primary and persistent.MethodsIn this guidance paper, we provide a systematic revi...

Full description

Bibliographic Details
Main Authors:	S. Galderisi, A. Mucci, S. Dollfus, M. Nordentoft, P. Falkai, S. Kaiser, G. M. Giordano, A. Vandevelde, M. Ø. Nielsen, L. B. Glenthøj, M. Sabé, P. Pezzella, I. Bitter, W. Gaebel
Format:	Article
Language:	English
Published:	Cambridge University Press 2021-01-01
Series:	European Psychiatry
Subjects:	Assessment instruments conceptualization persistent negative symptoms primary negative symptoms secondary negative symptoms
Online Access:	https://www.cambridge.org/core/product/identifier/S0924933821000110/type/journal_article

Similar Items

EPA guidance on treatment of negative symptoms in schizophrenia
by: S. Galderisi, et al.
Published: (2021-01-01)

Apathy in schizophrenia: assessment in clinical settings and overlap with other dimensions of impairment
by: A. Mucci, et al.
Published: (2021-04-01)

The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia
by: Paola Rucci, et al.
Published: (2023-09-01)

Negative symptoms assessment in early intervention settings: Implications for early identification and treatment
by: L.B. Glenthøj, et al.
Published: (2021-04-01)

Prediction of drop-out and functional impairment in recent-onset schizophrenia spectrum disorders
by: A. Mucci, et al.
Published: (2021-04-01)

Impaired Effort Allocation in Patients with Recent-Onset Schizophrenia and Its Relevance to Negative Symptoms Assessments and Persistent Negative Symptoms
by: Ezgi Ince Guliyev, et al.
Published: (2022-08-01)

Negative and Cognitive Symptoms of Schizophrenia: Are there Adequate Pharmacological Treatments?
by: O. Vasiliu
Published: (2022-06-01)

Pervalence of Negative Symptoms in Schizophrenia
by: Saeed Shoja-Shefti, et al.
Published: (2002-10-01)

Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features
by: Giovanni Stanghellini, et al.
Published: (2020-01-01)

Resting-state functional connectivity of the ventral tegmental area and negative symptom domains in subjects with schizophrenia
by: P. Pezzella, et al.
Published: (2021-04-01)

Assessment and Prediction of Negative Symptoms of Schizophrenia from RGB+D Movement Signals
by: Chakraborty, Debsubhra, et al.
Published: (2017)

Perception of burden by caregivers of patients with schizophrenia in relation to symptom profile
by: Bharathi Gunjahalli, et al.
Published: (2019-01-01)

Study of negative symptoms in schizophrenia
by: Phanikanth Kondaparthi, et al.
Published: (2020-01-01)

Negative Symptoms Management in Schizophrenia
by: Maria Francisca Intan Primasiwi Lolobua, et al.
Published: (2021-05-01)

Apathy in patients with schizophrenia: Treatment perspectives
by: S. Kaiser
Published: (2021-04-01)

Multivariate approach to identify electrophysiological markers for diagnosis and prognosis of schizophrenia
by: L. Giuliani, et al.
Published: (2021-04-01)

Negative symptoms in schizophrenia
by: Sayantanava Mitra, et al.
Published: (2016-01-01)

Correlation of Health-Related Quality of Life with Negative Symptoms Assessed with the Self-Evaluation of Negative Symptoms Scale (SNS) and Cognitive Deficits in Schizophrenia: A Cross-Sectional Study in Routine Psychiatric Care
by: Jonas Montvidas, et al.
Published: (2023-01-01)

Effectiveness of spironolactone on schizophrenia symptoms: A double-blind randomized clinical trial
by: Nazanin Hoghoughi, et al.
Published: (2023-08-01)

Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
by: P N Suresh Kumar, et al.
Published: (2016-01-01)

Management of cognitive and negative symptoms in schizophrenia
by: Megan Maroney, PharmD, BCPP
Published: (2022-11-01)

Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques
by: Ginetta Collo, et al.
Published: (2020-06-01)

Corrigendum: Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques
by: Ginetta Collo, et al.
Published: (2021-07-01)

Insight in schizophrenia: Relationship to positive, negative and neurocognitive dimensions
by: Boban Joseph, et al.
Published: (2015-01-01)

Associations between negative and positive automatic thoughts and clinical variables in patients with schizophrenia
by: Tomoya Takeda, et al.
Published: (2024-03-01)

Validation of the Arabic version of the “self-evaluation of negative symptoms” scale (SNS)
by: Aline Hajj, et al.
Published: (2020-05-01)

Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial
by: Somaieh Ashrafi, et al.
Published: (2022-01-01)

Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms
by: Koen Demyttenaere, et al.
Published: (2022-01-01)

The effect of active music therapy on the severity of positive and negative symptoms and performance in patients with schizophrenia
by: Afshin Ahmadvand, et al.
Published: (2024-04-01)

Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature
by: Giulia M. Giordano, et al.
Published: (2022-08-01)

Validation of the French Clinical Assessment Interview for Negative Symptoms in a Sample of Stable French Individuals With Schizophrenia
by: Yasmine Laraki, et al.
Published: (2022-04-01)

Schizophrenia: human and animal studies
by: Ahmed A. Moustafa, et al.
Published: (2016-04-01)

Clinical characteristics of patients with puerperal schizophrenia
by: Lu Xiaohua, et al.
Published: (2024-02-01)

Trait emotional experience in individuals with schizophrenia and youth at clinical high risk for psychosis
by: Claire I. Yee, et al.
Published: (2019-09-01)

Olfactory impairment in first-episode schizophrenia: a case-control study, and sex dimorphism in the relationship between olfactory impairment and psychotic symptoms
by: Xiacan Chen, et al.
Published: (2018-06-01)

Working memory and Parkinsonism due to antipsychotic medications in Schizophrenia
by: Amir eSalem, et al.
Published: (2015-05-01)

Negative symptoms - a real unmet need
by: I. Soares Da Costa, et al.
Published: (2022-06-01)

Marker of schizophrenia with enduring negative symptoms
by: E. Dmitrieva, et al.
Published: (2022-06-01)

Prevalence of spontaneous dyskinesia in first episode, drug naive schizophrenia, and its relation to the positive and negative symptoms of schizophrenia
by: Samrat Singh Bhandari, et al.
Published: (2017-06-01)

Modeling of affective-negative content in the course of schizophrenia
by: A. Barkhatova, et al.
Published: (2022-06-01)